Comparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes

scientific article (publication date: 2014)

Comparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...987799P
P356DOI10.1371/JOURNAL.PONE.0087799
P932PMC publication ID3948620
P698PubMed publication ID24614911
P5875ResearchGate publication ID260683013

P2093author name stringCheol-Young Park
Sung Woo Park
Suk Chon
Junghyun Noh
Jun Goo Kang
Chang Beom Lee
Seung Joon Oh
P2860cites workManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Q22241288
Epidemic obesity and type 2 diabetes in AsiaQ28273485
10-year follow-up of intensive glucose control in type 2 diabetesQ29615973
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trialQ33844615
Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitusQ34255525
Standards of medical care in diabetes--2011.Q34425055
2011 clinical practice guidelines for type 2 diabetes in KoreaQ35564049
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trialsQ37866586
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of CardQ41824843
Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.Q43115605
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trialQ44479625
Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysisQ44526957
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patientsQ44631767
Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetesQ44926596
Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.Q46195706
Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patientsQ46966714
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.Q51486848
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.Q51590615
Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT StudyQ58040220
Individualizing glycemic targets in type 2 diabetes mellitusQ84893062
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmetforminQ19484
insulin glargineQ417317
type 2 diabetesQ3025883
P304page(s)e87799
P577publication date2014-01-01
P1433published inPLOS OneQ564954
P1476titleComparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes
P478volume9

Reverse relations

cites work (P2860)
Q47176512Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
Q47094226Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
Q92128367BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion
Q52657004Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.
Q47142499Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017.
Q57217641Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
Q51276760Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination.

Search more.